• 한국토양비료학회지
• /
• 제40권2호
• /
• pp.114-117
• /
• 2007

가축용 구충제로 사용되어지고 있는 ivermectin이 토양 동물중 대표적인 비표적 생물인 지렁이(Eisenia fetida)에 미치는 영향을 조사하였다. Ivermectin $250{\mu}g$를 피하주사한 소로부터 배출되는 우분을 1, 2, 3, 7일째 채취하여 생물검정을 시도한 결과 1, 2일째 배출된 우분은 급성 독성을 나타내어 73.7%와 98.3%의 치사율을 보였다. 또한 발육율에 있어서도 1일째 우분을 섭취한 줄지렁이의 발육이 대조군에 비해 현저히 떨어지는 것으로 나타났고, 전혀 산란을 하지 못했다. Ivermectin 처리후 1, 2 일째 배출된 우분은 지렁이에 있어 급성독성을 나타내고 2세대의 부화율에도 영향을 미치지만, 3일째 이후 배출된 우분에서는 급성 및 만성독성은 나타나지 않았다. 결과적으로, ivermectin을 소에 처리하고 1, 2일째 배설된 우분에는 상당량의 ivermectin이 함유되어 지렁이등과 같은 분해성 비표적 생물의 발육에 영향을 미칠 수 있음이 관찰되어 초지에서 영양물질 순환의 차원에서나 지렁이 먹이로써의 우분에 대한 관리가 요망되는 바이다.

• 대한수의학회지
• /
• 제51권4호
• /
• pp.289-295
• /
• 2011

Toxocara (T.) canis and Trichuris (T.) vulpis are very important canine parasitic nematodes. T. canis parasitize in small intestine and T. vulpis parasitize in large intestine. In order to control of these nematodes, ivermectin and pyrantel pamoate compound was applied to the dogs infected with these parasites naturally and artificially. This drug was composed of $68.0{\mu}g$ of ivermectin and 57.0 mg of pyrantel pamoate for small animal, $136.0{\mu}g$ of ivermectin and 114.0 mg of pyrantel pamoate for middle animal, and $272.0{\mu}g$ of ivermectin and 227.0 mg of pyrantel pamoate for large animal. Ivermectin in this drug is activity to nematodes and ectoparisites. Pyrantel pamoate in this drug is also activity to nematodes. In this experiment, this drug had a good efficacy against T. canis and T. vulpis in the infected dogs.

• 대한수의학회지
• /
• 제37권4호
• /
• pp.855-862
• /
• 1997

Ivermectin is a synthetic derivative of the naturally occurring avermectin $B_{1a}$ (22, 23-dihydroavermectin $B_{1a}$) and $B_{1b}$ (22, 23-dihydroavermectin $B_{1b}$), It is widely used as antiparasitic and pesticidal agents because of its remarkably potent and broad spectrum of antiparasitic activity. Although the drug has shown excellent anthelmintic effects, development of toxicosis in some animals such as the Collie species of dog is well documented. However, no studies have been reported on the toxic effects of the drug in Korean native animals such as the Jindo dog. The toxic effect of ivermectin was evaluated in 25 Jindo dogs divided into five groups which were orally administered with ivermectin at dosage levels of $200{\mu}g/kg$, $300{\mu}g/kg$, $600{\mu}g/kg$ and $2,500{\mu}g/kg$ of body weight, respectively. Toxic signs were not observed in the groups receiving $200{\mu}g/kg$ and $300{\mu}g/kg$ B.W. ivermectin. One dog developed mild clinical signs of toxicosis in the group receiving $600{\mu}g/kg$ dosage of ivermectin. In the group with $2,500{\mu}g/kg$ dosage, all dogs developed mild (salivation, drooling, vomiting, mydriasis, and/or confusion) and/or moderate (ataxia and tremors) clinical signs of toxicosis. Hematologic changes were not observed in the groups receiving $200{\mu}g/kg$, $300{\mu}g/kg$ and $600{\mu}g/kg$ B.W. ivermectin. In the groups receiving $2,500{\mu}g/kg$ B.W., total erythrocyte counts, total and differential leukocyte counts and hemoglobin levels were not affected by drug. Aspartate aminotransferase levels were increased after administration of ivermectin, while serum cholesterol and blood glucose levels were decreased.

• 대한수의학회지
• /
• 제52권1호
• /
• pp.53-56
• /
• 2012

Dirofilaria (D.) immitis is an important canine parasitic nematode in dogs. D. immitis parasitizes the right ventricle and pulmonary artery of dogs. An ivermectin and pyrantel pamoate compound (IPPC) was administered to dogs naturally infected with this parasite. IPPC is composed of 68.0, 136.0 and $272.0{\mu}g$ of ivermectin and 57.0, 114.0 and 227.0 mg pyrantel pamoate for small, middle, and large animals. Ivermectin has activity against nematodes and ectoparasites in dogs. Pyrantel pamoate is also effective against nematodes in dogs. Our results showed that this drug combination has good efficacy in D. immitis infected dogs.

• 한국임상수의학회지
• /
• 제15권1호
• /
• pp.209-213
• /
• 1998

난치성 전신성 모낭충증에 감염되어 약 4개월간 모낭충 치료제인 amitraz(0.0125%) 처치에도 불구하고 치유되지 않은 한국산 풍산개 2두에 대한 ivermectin 및 amitraz 의 병용치료효과를 알아보았다. 전신성 모낭충증은 신체의 50% 또는 4개의 발에 모두 모낭충 이 검출된 것으로 정의하였다. 내원시 신체검사, 심장사상충검사 및 최소 裂訃위에 대한 피부 박리검사를 실시하여 모낭충을 진단하였고 치료는 돼지용 ivermectin을 체중 kg당 0.5 mg을 피하로 매일 주사하였으며 1주일에 2회 amitraz 약욕을 실시하였다. 피부농피중은 cephalexin 20 mg/kg을 경구로 일일 2회 투여하여 치료하였다. 치료후 4주에 피부병변이 치유되기 시 작하였으며 6주에는 탈모 및 소수의 발진을 제외하고는 피부병변이 정상으로 회복하였다. 피 부박리검사는 6주에 모낭충이 검출되지 않았다. 이들 제제에 의한 부작용은 관찰되지 않았으며 매일 ivermectin 투여와 amitraz 약욕치료의 병용치료는 amitraz로 치료가 되지 않는 난치성의 전신성 모낭충증에 대한 치료기간을 단축시키는 효과적인 치료방법으로 생각된다.

• 한국동물위생학회지
• /
• 제30권3호
• /
• pp.421-428
• /
• 2007

This study was conducted two kinds of aims: 1) to modify the analytical methods (conditions) by high performance liquid chromatography - fluorescence detector for the detection of residual ivermectin in raw milk, 2) to provide basic information for the evaluation of standard of the residual ivermectin in raw milk. It could be considerable that negative ion spectra can be better method in the LC/MS analysis for the detection of residues, Characteristic daughter ions were observed in negative ion spectra, however, linear line was not formed in positive ion one. Three Holstein cows ($500{\pm}10kg$) were applied to commercial ointment of ivermectin just one time at the first day of test, and residues in raw milk were examined for 20day after administration. The limit of detection (LOD) was 0.65ng (n=5) by HPLC/FLD, and recovery rates were $87.85%{\sim}99.47%$. The peak was observed at the 4th day, and residues lasted to the end. Thus ivermectin was prohibited when lactating.

• 대한수의사회지
• /
• 제23권11호
• /
• pp.723-728
• /
• 1987

This study was conducted to evaluate the anthelmintic efficacy of Ivermectin(Ivomec) against naturally infected gastrointestinal nematoeds, trematodes and cestode in Korean Native goats. Ivermectin was injected at a dose rate 0.2mg/kg of body weight subcu

• 한국임상수의학회지
• /
• 제28권4호
• /
• pp.442-445
• /
• 2011

Macrocyclic lactone에 저항이 있는 Parascaris equorum은 몇몇 국가에서 보고되었다. 그랜트얼룩말(Equus burchelli bohmi)이 만성체중감소 및 심한 침울로 인하여 제주경마공원동물병원에 내원하였다. 임상검사에서 빈맥 및 탈수가 밝혀졌고 다음날 심한 복통을 앓고 난 후 폐사하였다. 내원하기 전에 얼룩말은 3개월 간격으로 3회에 걸쳐 ivermectin을 경구로 투여 받았고 첫 침울증상 30일 전에도 ivermectin으로 투여 받았다. 부검에서 위와 소장에 회충축적 및 장천공을 확인하였다. 저자들의 지식으로는 성숙한 얼룩말에서 ascarid impaction 및 장천공 예가 매우 드물다. 본 증례의 원인은 P. equorum이 ivermectin에 저항성이 있을 수 도 있다고 의심하고 있다.

• Parasites, Hosts and Diseases
• /
• 제49권2호
• /
• pp.145-151
• /
• 2011

The comparative efficacy of 2 anthelmintics (ivermectin and levamisole) against Baylisascaris transfuga migrating and encapsulated larvae was studied in mice. A total of 60 BALB/c mice inoculated each with about 1,000 embryonated B. transfuga eggs were equally divided into 6 groups (A-F) randomly. Mice of groups A and B were treated with ivermectin and levamisole, respectively, on day 3 post-infection (PI). Mice of groups A-C were killed on day 13 PI. Similarly, groups D and E were treated with ivermectin and levamisole, respectively, on day 14 PI, and all mice of groups D-F were treated on day 24 PI. The groups C and F were controls. Microexamination was conducted to count the larvae recovering from each mouse. The percentages of reduction in the number of migrating larvae recovered from group A (ivermectin) and B (levamisole) were 88.3% and 81.1%, respectively. In addition, the reduction in encapsulated larvae counts achieved by ivermectin (group D) and levamisole (group E) was 75.0% and 49.2%, respectively. The results suggested that, to a certain extent, both anthelmintics appeared to be more effective against migrating larvae than encapsulated larvae. However, in the incipient stage of infection, ivermectin may be more competent than levamisole as a larvicidal drug for B. transfuga.

• 한국동물위생학회지
• /
• 제45권3호
• /
• pp.243-248
• /
• 2022

The HPLC conditions for analysis of ivermectin in solutions dosage forms of commercial anthelmintics are different for each product. The purpose of this study was to establish a standardized chromatographic method for the quantification of ivermectin in solution. The separation was achieved on Waters Xbridge C18 column (4.6×150 nm, 5 ㎛) using different kinds of mobile phase composed of water/methanol/acetonitrile (15/34/51, v/v and 19.5/27.5/53, v/v), with UV detection at wavelengths 245 nm and 254 nm. A total of five commercial ivermectin in solution samples were analyzed. In this study, the optimal chromatographic conditions for analysis of ivermectin in solution were mobile phase of water/methanol/acetonitrile (15/34/51, v/v) at a flow rate of 1.0 mL/min and a detection wavelength of 245 nm using a Waters Xbridge C18 column (4.6×250 nm, 5 ㎛) at a column temperature of 25℃. The linearity was observed in the concentration range of 50~150 ㎍/mL, with a correlation coefficient, r²= 0.99999. The limit of detection and the limit of quantification were 0.88 and 2.68 ㎍/mL, respectively. The accuracy (% recovery) was found to be 98.9 to 100.3%. Intra-day and Intermediate precisions with relative standard deviations were less than 1.0%. The content of ivermectin for five market samples ranged 91.2~102.7%. The proposed method was also found to be robust, therefore, the method can be used for the routine analysis of ivermectin in solutions dosage forms.